Optimizing Adjuvant Therapy for Localized Colon Cancer and Treatment Selection in Advanced Colorectal Cancer in: Journal of the National Comprehensive Cancer Network Volume 16 Issue 5S (2018)
Oxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment for Colon Cancer
PDF) Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to BRAF Mutation and Mismatch Repair Status of the MOSAIC Study
MOSAIC Data Support FOLFOX- 4 Use in High-Risk Stage II Colon Cancer
Oxaliplatin/5-FU/LV in Adjuvant Colon Cancer: Updated Efficacy Results of the Mosaic Trial, Including Survival, with a Median Follow-up of 6 Years Aimery. - ppt download
![Table 1 from [Chemotherapy for colorectal cancer]. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1aa850d41f53d06c3224b598001e97a93455b779/2-Table1-1.png "Table 1 from [Chemotherapy for colorectal cancer]. | Semantic Scholar")
Table 1 from [Chemotherapy for colorectal cancer]. | Semantic Scholar
Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to BRAF Mutation and Mismatch Repair Status of the MOSAIC Study | Journal of
Current stages of adjuvant treatment of colon cancer - Annals of Oncology
A Report from ASCO-GI 2008 and ASCO 2007 Up-to-Date Review of the Treatment of Adjuvant Colorectal Cancer Axel Grothey, MD Professor of Oncology Mayo Clinic. - ppt download
Association of post-operative CEA with survival and oxaliplatin benefit in patients with stage II colon cancer: a post hoc analysis of the MOSAIC trial | British Journal of Cancer
Oxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment for Colon Cancer | NEJM
![PDF] Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/037ec0de81994c4e5edf94d736d025133d72badf/3-Figure2-1.png "PDF] Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. | Semantic Scholar")
PDF] Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. | Semantic Scholar
Cost-Effectiveness of Adjuvant FOLFOX Therapy for Stage III Colon Cancer in Japan Based on the MOSAIC Trial - Value in Health
Adjuvant Chemotherapy for Stage II and III Colon Cancer: When, How, and for Whom
PPT - Adjuvant Chemotherapy for Colorectal Cancer PowerPoint Presentation - ID:4488184
Refining adjuvant therapy for non-metastatic colon cancer, new standards and perspectives - Cancer Treatment Reviews
Oxaliplatin/5FU/LV in adjuvant colon cancer: Updated efficacy results of the MOSAIC trial, including survival, with a median follow-up. - ppt download
Kaplan-Meier estimates of overall survival (OS) in the intent-to-treat... | Download Scientific Diagram
Oxaliplatin/5FU/LV in adjuvant colon cancer: Updated efficacy results of the MOSAIC trial, including survival, with a median follow-up. - ppt download
Oxaliplatin/5FU/LV in adjuvant colon cancer: Updated efficacy results of the MOSAIC trial, including survival, with a median follow-up. - ppt download
Rationale and Design of the IROCAS Study: Multicenter, International, Randomized Phase 3 Trial Comparing Adjuvant Modified (m) FOLFIRINOX to mFOLFOX6 in Patients With High-Risk Stage III (pT4 and/or N2) Colon Cancer—A UNICANCER
Effect of duration of adjuvant chemotherapy for patients with stage III colon cancer (IDEA collaboration): final results from a prospective, pooled analysis of six randomised, phase 3 trials - The Lancet Oncology
Impact of age and medical comorbidity on adjuvant treatment outcomes for stage III colon cancer: a pooled analysis of individual patient data from four randomized, controlled trials - Annals of Oncology
Early stage colon cancer: Current treatment standards, evolving paradigms, and future directions
Deciding the Duration of Adjuvant Chemotherapy in a Patient With Stage III Colon Cancer: When Can Less Be More?
MOSAIC Data Support FOLFOX- 4 Use in High-Risk Stage II Colon Cancer
Oxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment for Colon Cancer | NEJM
Overall survival in stage II vs stage III patients (4-year follow-up in... | Download Scientific Diagram
